Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study.

Autor: Borin, Marie T.1 (AUTHOR), Barnes, Chris N.1 (AUTHOR), Darpo, Borje2 (AUTHOR), Pendyala, Srikanth1 (AUTHOR), Xue, Hongqi2 (AUTHOR), Bourdet, David L.1 (AUTHOR) dbourdet@theravance.com
Zdroj: Clinical Pharmacology in Drug Development. Jan2020, Vol. 9 Issue 1, p130-139. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje